CHARLOTTE – A clinical trials company based in Winston-Salem has raised $9.4 million from five investors, according to a Securities and Exchange Commission filing.
Javara Inc. raised the money by selling debt, according to the filing.
The company is an integrated research organization, which is different than a clinical research organization.
Traditionally clinical trials are conducted at the same study sites with the same groups of patients. This, according to Javara, leads to inequities and inefficiencies, and in the end, delayed trials of new drugs.
Instead, Javara partners with large healthcare organizations to provide access to broader and more diverse patient populations. Its partners include Atrium Health Wake Forest Baptist, Mankato Clinic, Nevada Health Centers, Privia Medical Group and Tryon Medical Partners.